An International Observational Study of Adults With Acute Infection

Purpose

Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to develop key design features of trials. Observational studies can be particularly important for establishing an early knowledge base after emergence of a new pathogen, as illustrated by the recent emergence of influenza A (H1N1), SARS-CoV-2, and Mpox. This observational study protocol describes collection of data and biospecimens from sites across the world for characterizing acute infections in hospitalized patients. The protocol is designed to study respiratory infections, infections outside the respiratory tract, established infectious diseases, and emerging infectious diseases. Data generated in this study will be used to efficiently characterize acute infectious diseases and plan future clinical trials.

Condition

  • Infectious Disease

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥18 years old - Admitted to hospital (or in an emergency department with anticipated hospital admission) for the management of a suspected or confirmed acute infectious disease. - Onset of symptoms of an infectious disease within the past 30 days. - Informed consent for study participation by the participant or a surrogate decision maker if the participant lacks capacity for consent.

Exclusion Criteria

  • Current imprisonment (this does not include quarantine for an infectious disease). - Patient undergoing comfort care measures only such that treatment focuses on end- of-life symptom management over prolongation of life. - Expected inability or unwillingness to participate in study procedures. - In the opinion of the investigator, participation in the study is not in the best interest of the patient.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Study group The study population includes adult patients admitted to a hospital with a suspected or confirmed acute infection.
  • Other: No intervention
    This is an observational study

Recruiting Locations

Banner University Medical Center Tucson
Tucson, Arizona 85719
Contact:
Nashville ICC
icsarinash@strive-network.org

Stanford University Hospital & Clinics (Site 203-003)
Palo Alto, California 94305
Contact:
Nashville ICC
icsarinash@strive-network.org

UCSF Medical Center (Site 203-001)
San Francisco, California 94143
Contact:
Nashville ICC
icsarinash@strive-network.org

Orlando VA Medical Center (074-032)
Orlando, Florida 32827
Contact:
Washington ICC
icsariwdc@strive-network.org

University of Illinois at Chicago (Site 008-012)
Chicago, Illinois 60612
Contact:
Hennepin ICC
icsarihenn@strive-network.org

University of Kansas Medical Center (Site 080-044)
Kansas City, Kansas 66160
Contact:
Hennepin ICC
icsarihenn@strive-network.org

Mayo Clinic (Site 054-001)
Rochester, Minnesota 55905
Contact:
Hennepin ICC
icsarihenn@strive-network.org

University of Nebraska Medical Center (Site 080-045)
Omaha, Nebraska 68198-5400
Contact:
Hennepin ICC
icsarihenn@strive-network.org

New York University Langone Health (301-013)
New York, New York 10016
Contact:
New York ICC
icsariny@strive-network.org

Mount Sinai Medical Center (Site 301-012)
New York, New York 11234
Contact:
New York ICC
icsariny@strive-network.org

Duke University (301-006)
Durham, North Carolina 27710
Contact:
New York ICC
icsariny@strive-network.org

Wake Forest Baptist Health (210-001)
Winston-Salem, North Carolina 27157
Contact:
Nashville ICC
icsarinash@strive-network.org

Cleveland Clinic Foundation (Site 207-001)
Cleveland, Ohio 44195
Contact:
Nashville ICC
icsarinash@strive-network.org

Vanderbilt University Medical Center (Site 212-001)
Nashville, Tennessee 37232
Contact:
Nashville ICC
icsarinash@strive-network.org

UT Southwestern Medical Center (084-001)
Dallas, Texas 75390
Contact:
Washington ICC
icsariwdc@strive-network.org

MEDVAMC (Site 074-006)
Houston, Texas 77030-4211
Contact:
Washington ICC
icsariwdc@strive-network.org

Intermountain Medical Center (Site 211-001)
Murray, Utah 84107
Contact:
Nashville ICC
icsarinash@strive-network.org

West Virginia University Medicine (301-023)
Morgantown, West Virginia 26506
Contact:
New York ICC
icsariny@strive-network.org

More Details

Status
Recruiting
Sponsor
University of Minnesota

Study Contact

Rebecca Schoenecker
612-624-9644
webe0376@umn.edu